Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis

Systematic review
Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, Raatz H
Swiss Med Wkly. 2019;149:w20093

The clinical efficacy and safety of combination therapy with acetylcholinesterase inhibitors (AChEI) and memantine compared to AChEIs or memantine alone in patients with Alzheimer’s disease is inconclusive.

Rationale and methods of an observational study to support the design of a nationwide surgical registry: the MIDAS study

Original article
Vach W, Saxer F, Holsgaard-Larsen A, Overgaard S, Farin-Glattacker E, Bless N, Bucher HC, Jakob M
Swiss Med Wkly. 2018;148:w14680

Surgical registries are becoming increasingly popular, and Swiss legislation requires data on therapeutic outcome quality. The Swiss Association of Surgeons has agreed on a first minimum data set for a nationwide registry.

Effects of maternal caffeine consumption on the breastfed child: a systematic review

Systematic review
McCreedy A, Bird S, Brown LJ, Shaw-Stewart J, Chen YF
Swiss Med Wkly. 2018;148:w14665

Caffeine is a central nervous system stimulant occurring naturally in some foods and used to treat primary apnoea in premature babies. However, high caffeine intake can be harmful, and caffeine is transmitted into breastmilk.

Video analysis for the evaluation of vaginal births: a prospective observational study

Original article
Kimmich N, Zimmermann R, Kreft M
Swiss Med Wkly. 2018;148:w14634

The aim of video documentation during labour is to provide an observational tool for obstetric care by midwives and obstetricians, with the opportunity for evaluation and education afterwards.

The inconsistent ethical oversight of healthcare quality data in Switzerland

Viewpoint
McLennan S, Maritz R, Shaw D, Elger B
Swiss Med Wkly. 2018;148:w14637

Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.

Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight

Systematic review
Ademi Z, Tomonaga Y, van Stiphout J, Glinz D, Gloy V, Raatz H, Bucher HC, Schwenkglenks M
Swiss Med Wkly. 2018;148:w14626

There is a relatively broad international literature on the cost effectiveness of bariatric surgery, but no systematic reviews that examine the transferability of international cost-effectiveness results for Switzerland or another single country.

Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials

Systematic review
Martínez-González NA, Plate A, Senn O, Markun S, Rosemann T, Neuner-Jehle S
Swiss Med Wkly. 2018;148:w14584

Men facing prostate cancer screening and treatment need to make critical and highly preference-sensitive decisions that involve a variety of potential benefits and risks. Shared decision-making is considered fundamental for “preference-sensitive” medical decisions.

Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study

Original article
Amstutz A, Schandelmaier S, Frei R, Surina J, Agarwal A, Alturki R, von Niederhäusern B, von Elm E, Briel M, on behalf of the MAking Randomized Trials Affordable (MARTA) Group
Swiss Med Wkly. 2018;148:w14587

Failure to publish publicly funded research represents a waste of scarce research ­resources. In Switzerland, about 40% of randomised clinical trials supported by the Swiss National Science Foundation were not published.

Teamwork in rehabilitation – it is effective but it must be financed

Viewpoint
Kesselring J, Oesch P
Swiss Med Wkly. 2017;147:w14449

There is urgent need for further research and development in the fields of musculoskeletal rehabilitation.

Prevalence of tobacco smoking in Switzerland: do reported numbers underestimate reality?

Original article
Jakob J, Cornuz J, Diethelm P
Swiss Med Wkly. 2017;147:w14437

Could it be that legislators and other public health professional base their tobacco control policy decisions on smoking prevalence estimates that are more reassuring than may be justified?

Verpassen Sie keinen Artikel!

close